179 related articles for article (PubMed ID: 1353877)
1. Discerning malignancy in human adrenocortical neoplasms: utility of DNA flow cytometry and immunohistochemistry.
Suzuki T; Sasano H; Nisikawa T; Rhame J; Wilkinson DS; Nagura H
Mod Pathol; 1992 May; 5(3):224-31. PubMed ID: 1353877
[TBL] [Abstract][Full Text] [Related]
2. Adrenal cortical adenoma and adrenal metastasis of renal cell carcinoma: immunohistochemical and DNA ploidy analysis.
Kumar D; Kumar S
Mod Pathol; 1993 Jan; 6(1):36-41. PubMed ID: 7678935
[TBL] [Abstract][Full Text] [Related]
3. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas.
Iino K; Sasano H; Yabuki N; Oki Y; Kikuchi A; Yoshimi T; Nagura H
Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953
[TBL] [Abstract][Full Text] [Related]
4. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
[TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
[TBL] [Abstract][Full Text] [Related]
7. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
[TBL] [Abstract][Full Text] [Related]
8. [The use of flow cytometry in the study of parathyroid hyperplasia and adenomas].
Mangili F; Sassi I; Schiaffino E; Zogno C; Cantaboni A; Schmid C
Pathologica; 1992; 84(1092):459-65. PubMed ID: 1491887
[TBL] [Abstract][Full Text] [Related]
9. [Histology, immunocytochemistry and DNA cytophotometry of adrenocortical tumors--a clinicomorphological study of 72 tumors].
Schröder S; Padberg BC; Achilles E; Lauritzen I; Dralle H; Klöppel G
Verh Dtsch Ges Pathol; 1990; 74():284-8. PubMed ID: 1708604
[TBL] [Abstract][Full Text] [Related]
10. Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma.
Wick MR; Cherwitz DL; McGlennen RC; Dehner LP
Am J Pathol; 1986 Feb; 122(2):343-52. PubMed ID: 2418689
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
12. Image cytometric DNA analysis of adrenocortical neoplasms as a prognostic parameter: a clinico-pathologic study of 13 patients.
Lü X; Stallmach T; Gebbers JO
Anal Cell Pathol; 1996 Oct; 12(1):1-11. PubMed ID: 8933905
[TBL] [Abstract][Full Text] [Related]
13. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
Takehara K; Sakai H; Shono T; Irie J; Kanetake H
Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity and aneuploidy in pleomorphic adenomas of the salivary glands.
Martin AR; Mantravadi J; Kotylo PK; Mullins R; Walker S; Roth LM
Arch Pathol Lab Med; 1994 Mar; 118(3):252-9. PubMed ID: 7907855
[TBL] [Abstract][Full Text] [Related]
16. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.
Dabbs DJ
Mod Pathol; 1995 Aug; 8(6):637-42. PubMed ID: 8532697
[TBL] [Abstract][Full Text] [Related]
17. Myoepithelial tumors of salivary glands: a clinicopathologic, immunohistochemical, ultrastructural, and flow-cytometric study.
Alós L; Cardesa A; Bombí JA; Mallofré C; Cuchi A; Traserra J
Semin Diagn Pathol; 1996 May; 13(2):138-47. PubMed ID: 8734420
[TBL] [Abstract][Full Text] [Related]
18. DNA flow cytometry of endoscopically examined colorectal adenomas and adenocarcinomas.
Giaretti W; Sciallero S; Bruno S; Geido E; Aste H; Di Vinci A
Cytometry; 1988 May; 9(3):238-44. PubMed ID: 3378458
[TBL] [Abstract][Full Text] [Related]
19. [Flow-cytometric study of the DNA content in adrenal cortex tumors].
Tóth M; Molnár G; Schaff Z; Rácz K; Kiss R; Fütö L; Varga I; Gláz E; Lapis K
Orv Hetil; 1993 Jun; 134(26):1411-5. PubMed ID: 8332362
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
